Selina Sekulic
Foot & Ankle Surgery · Salt Lake City, UTNPI 1891082830
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (52.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Paragon 28, Inc. at 41.0% of the total. Reporting peaked in 2022 at $3,177 and has fallen 99.1% since, to $30 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in UT, where the typical reported total is $3,480.
Across 80 payments — averaging $48.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$2K
- Treace Medical Concepts, Inc.$2K
- Zyla Life Sciences, Inc.$310
- Amgen$90
- Assertio Therapeutics, Inc.$81
- Stryker$64
- plus $185 from 8 others
What the payments were for
- Travel & lodging$2,03552%
- Food & beverage$1,84047%
- Education$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 3 | $1,592 |
| Treace Medical Concepts, Inc. | 14 | $1,558 |
| Zyla Life Sciences, Inc. | 38 | $310 |
| Amgen | 5 | $90 |
| Assertio Therapeutics, Inc. | 7 | $81 |
| Stryker | 3 | $64 |
| Kowa Pharmaceuticals America, Inc. | 2 | $46 |
| Smith+Nephew | 2 | $34 |
| Orthofix Medical, Inc. | 1 | $29 |
| Aroa Biosurgery Incorporated | 1 | $20 |
| Amniox Medical, Inc. | 1 | $17 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
| Zimmer Biomet | 1 | $14 |
| Baudax Bio Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$1,592
- Lapiplasty System$1,164
How this compares
$3,880 in reported general payments places this provider in the 50th percentile of 104 foot & ankle surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 14 | $263 |
| Meloxicam | 34 | $181 |
| Doxycycline Hyclate | 12 | $167 |
| Gabapentin | 32 | $124 |
| Methylprednisolone | 11 | $79 |
| Silver Sulfadiazine | 13 | $71 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Salt Lake City
- Gregory AndersonSalt Lake City$1.6M
- Florian NickischSalt Lake City$474K
- Brian LiljenquistSalt Lake City$263K
- Douglas TooleSalt Lake City$258K
- David SeegmillerSalt Lake City$120K
- Grant SunSalt Lake City$11K
- Amanda KhourySalt Lake City$10K
- Callie MorlockSalt Lake City$9K
- Jordan ButterfieldSalt Lake City$7K
- Daniel PreeceSalt Lake City$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.